Exocrine Restoration
Restore the pancreatic digestive function function lost to disease or injury
The goal is to restore pancreatic digestive function function that disease or injury has taken — restoring the pancreas’s digestive function when disease or damage impairs it. This matters because of who is on the other side of it: people who would get their health, and their independence, back.
The pancreas makes both the insulin that controls blood sugar and the enzymes that digest food. When its insulin-producing cells are lost, diabetes follows and means lifelong injections; when its digestive function fails, nutrition suffers. Restoring the body’s own insulin and digestive capacity would change diabetes and pancreatic disease at the root. For someone with diabetes, restoring the body’s own insulin is the difference between managing a disease and being free of it.
We are building the capability to restore pancreatic digestive function: rebuilding or replacing what is lost and combining repair with targeted rehabilitation. The work runs from proven clinical care now to the frontier science still maturing — and this page marks exactly where each piece stands.
How it works
Replacing what is lost Demonstrated in research
Cell and tissue therapies rebuild lost function in research and early studies.
Supporting function today Clinical
Established clinical treatments restore or support lost function now.
Full functional restoration Frontier
Restoring complete, durable function is an active laboratory frontier.
Pairing repair with rehabilitation Clinical
Combining tissue or cell repair with intensive, targeted rehabilitation drives the fullest functional recovery — established in practice.
Cited as evidence the capability is real — not as partners or endorsers.
Government & programs
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) · NIH diabetes programs. These public programs fund the foundational research that shows the capability is real.
Universities & institutes
Academic diabetes, islet-biology, and pancreas-regeneration research centers. Academic laboratories carry that science from discovery toward the clinic.
Enabling science base
beta-cell & islet biology · stem-cell-derived islets · exocrine biology · immune tolerance. — the established disciplines this capability is built upon.
The technologies: stem-cell-derived insulin-producing cells, islet replacement and protection, exocrine-restoration approaches, and immune-tolerance therapies that protect new cells.
Tissue repair Demonstrated
Cell and tissue therapies rebuild function in research.
Clinical support Clinical
Treatments restore function today.
Full restoration Frontier
Complete restoration is early-stage.
Clinical translation underway Clinical trials
Several restorative approaches have moved from the lab into human trials — the bridge from demonstrated biology to everyday care.
The honest challenges: partial restoration and support are within reach; complete, durable restoration is frontier. Clinical support exists today; deep regeneration is demonstrated-to-frontier. Getting new cells and tissue to survive, connect, and function durably in a living person — not just in a dish or an animal — is the central work, and it is exactly where the most careful, best-funded research is now aimed. We show where each piece stands, so the promise is never mistaken for the proof.
The future, fully built
Function that pancreatic digestive function lost to disease or injury is restored — tissue rebuilt, capability regained — so loss becomes recoverable. — and the honest staging on this page shows just how much of that future is already real, and how much is still being built.
The proof, for this capability
Cited as evidence the capability is real, not as partners or endorsers.
Tissue/cell therapy
Therapies rebuild function in research and early studies. Stage: Demonstrated.
Clinical support
Treatments restore function today. Stage: Clinical.
Full restoration
Complete durable restoration is early-stage. Stage: Frontier.
Honest framing
Real organizations are cited as evidence the capability is real — not as partners or endorsers. Support is clinical; full functional restoration in people is demonstrated-to-frontier and not claimed as routine.
Where it stands
Each line above is tagged for its stage — demonstrated, clinical, or frontier — so the page shows exactly how far the real science has come, and how far is left.
Help build this future
Every signature grows the movement to make exocrine restoration real — and free at the point of need.